(Q37630581)

21 August 2017

1 reference

title

Challenges in defining predictive markers for response to endocrine therapy in breast cancer (English)

1 reference

21 August 2017

1

Alexey A Larionov

1 reference

21 August 2017

William R Miller

2

1 reference

21 August 2017

language of work or name

English

0 references

publication date

1 November 2009

1 reference

21 August 2017

1 reference

21 August 2017

volume

5

1 reference

21 August 2017

issue

9

1 reference

21 August 2017

page(s)

1415-1428

1 reference

Biological determinants of endocrine resistance in breast cancer

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.113

Source of Estrogen Production in Postmenopausal Women1

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.113

Prospects of neoadjuvant aromatase inhibitor therapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.113

Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.113

Neoadjuvant endocrine therapy for locally advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.113

Neoadjuvant use of endocrine therapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.113

Gene expression profiles differentiating between breast cancers clinically responsive or resistant to letrozole

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.113

Changes in breast cancer transcriptional profiles after treatment with the aromatase inhibitor, letrozole

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.113

Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.113

The scientific value of preoperative studies and how they can be used

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.113

Ultrasonography as a method of measuring breast tumour size and monitoring response to primary systemic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.113

Lessons from the use of aromatase inhibitors in the neoadjuvant setting

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.113

Effect of neoadjuvant treatment with anastrozole on tumour histology in postmenopausal women with large operable breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.113

Pathological features of breast cancer response following neoadjuvant treatment with either letrozole or tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.113

Biological and clinical effects of aromatase inhibitors in neoadjuvant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.113

Proliferation, steroid receptors and clinical/pathological response in breast cancer treated with letrozole

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.113

Clinical and biomarker endpoint analysis in neoadjuvant endocrine therapy trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.113

Molecular response to aromatase inhibitor treatment in primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.113

Patterns and changes in gene expression following neo-adjuvant anti-estrogen treatment in estrogen receptor-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.113

Short-term presurgical treatment for all?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.113

Benefit from adjuvant tamoxifen therapy in primary breast cancer patients according oestrogen receptor, progesterone receptor, EGF receptor and HER2 status

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.113

Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.113

Recommendations for collection and handling of specimens from group breast cancer clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.113

Real-time quantitative RT-PCR shows variable, assay-dependent sensitivity to formalin fixation: implications for direct comparison of transcript levels in paraffin-embedded tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.113

RNA extraction for arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.113

Complementary techniques: laser capture microdissection--increasing specificity of gene expression profiling of cancer specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.113

Molecular classification of tamoxifen-resistant breast carcinomas by gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.113

Limitations of mRNA amplification from small-size cell samples

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.113

Options available for profiling small samples: a review of sample amplification technology when combined with microarray profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.113

The RIN: an RNA integrity number for assigning integrity values to RNA measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.113

RNA quality in frozen breast cancer samples and the influence on gene expression analysis--a comparison of three evaluation methods using microcapillary electrophoresis traces

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.113

Multiplex polymerase chain reaction: a practical approach

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.113

Nanoliter high-throughput PCR for DNA and RNA profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.113

Real-time DNA microarrays: reality check

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.113

Large scale real-time PCR validation on gene expression measurements from two commercial long-oligonucleotide microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.113

Elimination of laboratory ozone leads to a dramatic improvement in the reproducibility of microarray gene expression measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.113

The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.113

Cross-platform comparison of SYBR Green real-time PCR with TaqMan PCR, microarrays and other gene expression measurement technologies evaluated in the MicroArray Quality Control (MAQC) study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.113

The real-time polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.113

Gene expression arrays in cancer research: methods and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.113

Microarray data analysis: from disarray to consolidation and consensus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.113

Microarray truths and consequences.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.113

Scanning microarrays: current methods and future directions.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.113

Effect of various normalization methods on Applied Biosystems expression array system data

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.113

Bioinformatics applications for pathway analysis of microarray data

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.113

Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.113

Validation of biomarker-based risk prediction models

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.113

Prediction error estimation: a comparison of resampling methods

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.113

Gene expression predictors in breast cancer: current status, limitations and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.113

MicroRNAs: novel biomarkers for human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.113

The context and potential of epigenetics in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.113

Comparative genomic hybridisation arrays: high-throughput tools to determine targeted therapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.113

Next-generation sequencing: from basic research to diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.113

RNA-Seq: a revolutionary tool for transcriptomics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.113

Development of the 21-gene assay and its application in clinical practice and clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.113

Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.113

Predicting response and resistance to endocrine therapy: profiling patients on aromatase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.113

Algorithm for in vitro diagnostic multivariate index assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.113

Roadmap for developing and validating therapeutically relevant genomic classifiers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.113

Recommendations from the EGAPP Working Group: can tumor gene expression profiling improve outcomes in patients with breast cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.113

Is molecular profiling ready for use in clinical decision making?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.113

21 January 2018

Identifiers

DOI

10.2217/FON.09.113

1 reference

21 August 2017

1 reference